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Background: Endoscopy-assisted breast surgery (EABS), a technique that optimizes cosmetic outcome because
it is performed through small wounds hidden in inconspicuous areas, could be an alternative surgical technique
for benign breast tumors. In this study, we report the preliminary results of 323 EABS procedures performed at our
institution for the management of benign breast tumors.
Methods: The medical records of patients who underwent EABS for benign breast lesions during the periods
August 2010 to December 2015 were collected from the Changhua Christian Hospital EABS database. Data on
clinicopathologic characteristics, type of surgery, hospital stay, and complications were analyzed to determine the
effectiveness of the procedure for benign breast tumors. The operating time with the number of procedure
performed was analyzed for learning curve evaluation. Patient satisfaction with cosmetic outcome was evaluated
with a self-report questionnaire.
Results: A total of 323 EABS procedures were performed in 286 patients with benign breast lesions, including 249
(90.5%) patients with unilateral lesions. The mean age was 36 years, the mean tumor size was 2.2 cm, and the mean
distance from the nipple to the tumor was 5.2 cm. Most (93.8%, 303/323) of these tumors were excised through a
transareolar wound, 2.4% (8/323) through an axillary wound, and 0.3% (1/323) through the infra-mammary fold.
Histopathologic analysis revealed that 63.5% (202/318) of the tumors were fibroadenoma-related lesions. The
mean operative time was 81.4 min (59~89 min), which was decreased with experience increased. The overall
rate of complications was 6.5%, and all were minor and wound-related. Among the 110 patients who participated in
the self-report cosmetic outcome evaluation, 85.4% reported being satisfied with the cosmetic result, and almost all
were satisfied with breast symmetry. Of the patients interviewed, 92.7% reported that they would choose the same
procedure if they had to undergo the operation again.
Conclusions: Our preliminary results show that transareolar video-assisted breast surgery is a safe and effective
procedure with good cosmetic outcome and that it could be appropriate for patients with moderate to large
peripherally located breast tumors.
Trial registration: CCH-IRB No.15115. Registered 14 December 2015 (retrospectively registered).
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Breast masses in young patients are usually benign in
nature and are most commonly fibroadenomas, cysts,
or fibrocystic lesions [1, 2]. Management of benign
breast tumors ranges from non-operative conservative
treatment to surgical excision [3–7]. Asymptomatic
tumors are often managed with observation [3, 5, 7];
however, patients who present with a progressively en-
larging mass, a tumor that is atypical in presentation,
or with breast deformity may request surgical excision.
The goal of surgical excision of benign breast tumors
is the complete excision of the tumor with a thin rim of
normal tissue [1, 5, 7]. Most (70%) breast tumors are
single and unilateral, which allows for volume-dependent
local excision to be carried out safely [1, 5, 7]. Usually, the
normal parenchyma will reestablish its shape and achieve
subsequent symmetry with time [8]. Although conven-
tional excision is a safe and effective method for managing
benign breast tumors, the procedure can result in subopti-
mal cosmetic outcomes such as conspicuous scars and
misshapen breasts caused by cavity collapse after resection
of the tumor.
Endoscopy-assisted breast surgery (EABS), a technique
performed through minimal axillary and/or periareolar
incisions, was initially developed to facilitate breast aug-
mentation [9–11] but is now increasingly used to excise
benign breast tumors [12–14], resect malignant breast
tumors [15–18], and assist in sentinel lymph node bi-
opsy [19, 20]. EABS, a modality that optimizes cosmetic
outcome because it is performed through small wounds
hidden in inconspicuous areas, could be an alternative
surgical technique for the management of benign breast
tumors.
In this study, on our preliminary experience perform-
ing 323 EABS procedures for the management of benign
breast tumors, we present the technique of video-
assisted breast surgery, the indications for surgery, the
preliminary outcomes, the learning curve associated with
EABS, and the patient-reported cosmetic outcomes.Methods
Data on patients with benign breast diseases who under-
went endoscopy-assisted surgery at the Changhua
Christian Hospital during the periods August 2010 to
December 2015 were collected from the hospital’s
EABS database. The data included clinicopathologic
characteristics, type of surgery, operation time, blood
loss, hospital stay, and complications. The data collec-
tion was performed by a specially trained nurse (SLC),
and the correctness of the data was checked by the
principal investigator (HWL). This study was approved
by the institutional review board (IRB) of the Changhua
Christian Hospital (IRB No. 151115).Patient selection criteria
Preoperative sonograms and/or mammograms were used
to determine the eligibility of patients for EABS. Indica-
tions for EABS included a tumor size greater than 2 cm
located in zone II or III (Fig. 1a) and or tumor size 1–2 cm
with patient’s preferences. Zone I breast tumors were
excised with or without endoscopic guidance. Patients for
whom EABS was contraindicated included patients with
severe comorbid conditions, such as heart disease, renal
failure, liver dysfunction, and poor performance status as
assessed by the primary physicians. The instruments used
during endoscopic benign breast excision are illustrated in
Fig. 1b and summarized in the endoscopy-assisted breast
surgery technique section (Fig. 2).
Learning curve evaluation
To evaluate the learning curve associated with EABS and
survey whether the operating time would decrease with
experience, we compared the operating time in different pe-
riods. Initially, we listed each procedure with corresponding
operating time, which includes both of the unilateral and bi-
lateral breast surgeries. Then, we divided all of the unilateral
procedures into five groups of 43–50 procedures per group
(only single-sided surgery was included to prevent bias from
bilateral surgeries). Finally, we analyzed the first 50 and last
50 EABS procedures to see the difference in operating time
between the initial phase and the mature phase.
Esthetic outcome evaluation
The cosmetic outcome was evaluated objectively by patients
with a self-report questionnaire 2 months after the operation
when their wounds had healed. The patients were asked to
compare the pre and postoperative breast shape, nipple
position, and volume symmetry of both breasts.
The self-report questionnaire comprised three questions:
1. Are you satisfied with the cosmetic outcome? The
esthetic result was graded as “very good,” “good,”
“fair,” and “poor.” Patients who reported “very good”
or “good” results were defined as being satisfied with
the outcome.
2. How do you feel about the symmetry of the breast
after surgery? The result was graded as “symmetric,”
“mildly asymmetric,” “moderately asymmetric,” and
“poor.”
3. Would you choose the same operation if you
required the surgery again? The possible responses
were “yes,” “not sure,” and “no.”
Endoscopy-assisted breast surgery technique
Details of the surgical technique for EABS used at our
hospital have been described previously [21, 22]. Briefly,
after preoperative marking, the patient was placed in a
supine position, and the arm was adducted for the
Fig. 1 a Illustration and classification of breast tumor location according to different anatomic zones. b Instruments
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approach to avoid disturbing the operative procedure.
Intraoperative sonography was routinely used to identify
the location of breast tumors, and a small amount of gel
containing blue dye was injected to mark the planned
resection line on the mammary gland to ensure theFig. 2 Illustration of surgical procedures: a Mark the planned resection line on
the subcutaneous layer with tumescent solution. c Tunneling method. d Subc
fascia dissection (with handle light retractor). f Removal of the specimen. g M
solution injection. i Tunnel creation. j Hand-made wound edge protector (wa
(under endoscopic guidance). l Posterior wall fascia dissection (with handle ligadequate removal of breast tumors, which sometimes
were non-palpable (Fig. 2a, g).
Endoscopic video monitors (Olympus Optical Co.,
Tokyo, Japan) were set up on both sides of the patient’s
head and watched by two surgeons. An ended, ridged
endoscope measuring 3 mm in diameter with a viewingthe mammary gland by gel containing blue dye. b Hydrodissection of
utaneous flap creation (under endoscopic guidance). e Posterior wall
arking the planned resection by gel containing blue dye. h Tumescent
terproof sticker fixed by running suture with 4–0 nylon). k Flap creation
ht retractor).m Removal of the specimen. n Postoperative gross picture
Table 1 Clinical manifestations of patients received endoscopy-
assisted breast surgery for benign disease
N = 286 patients, 323 EABS
Patient
Gender (female) 323 (100%)
Age (years old) 36 ± 13 (range 13–69)
<20 31 ± 1(9.5%)
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solution (lactated Ringer’s solution 100 ml containing
5 ml sodium bicarbonate, 20 ml 1% lidocaine, and epi-
nephrine 0.5 ml (1:1000)) was injected subcutaneously
into the whole breast to minimize bleeding (Fig. 2b, h).
A periareolar skin incision (one third or semi-periareolar)
or axillary incision (when the tumor was located near the
axilla) was made. A skin flap measuring 3–5 mm in
thickness was created using an Xcel optical bladeless trocar
(Johnson & Johnson, Tokyo, Japan) under endoscopic guid-
ance or an Xcel trocar blindly (Fig. 2c, i). The wound edge
protector, which is a waterproof patch fixed with 4–0 nylon
sutures, was placed to prevent wound maceration (Fig. 2j).
The septa between the skin flap and parenchyma were
dissected under direct vision initially and then using
bipolar scissors (Powers Star, Johnson & Johnson KK)
under endoscopic guidance. The subcutaneous flap was
dissected beyond the blue hue tissue under endoscopic
guidance to create the work space (Fig. 2k). After
enough space had been created, the breast parenchyma
was resected with an electrocoagulater and a light
retractor under direct vision (Fig. 2d, l). Tumor speci-
mens were removed through the periareolar wound.
Once all tumors had been resected, the gland was recon-
structed by undermining, advancing, and performing a
layered closure of the flanking glandular breast tissue
using 3–0 absorbable sutures [2]. The wound protector
was removed, and the wound was closed with 3–0 poly-
sorb and 4–0 monocryl sutures (Fig. 2n).20–40 175 ± 6 (54.1%)






Distance to nipple (cm) 5.22 ± 1.14 cm (2–9 cm)
Characteristics of massStatistical analyses
Data are reported as means ± standard deviation (SD).
Differences in continuous variables were tested by the
independent t test. The chi-square test was used for
categorical comparisons of data when appropriate. A p
value of less than 0.05 was considered to indicate statis-
tical significance; all tests were two-tailed. All statistical
analyses were performed with the statistical package
SPSS (Version 19.0, SPSS, Chicago).Sonogram mean tumor size 2.9 ± 3.93 cm (0.62–20 cm)
<2 cm 150 (46%)
>2 cm 136 (42%)
Pathology mean tumor size 2.2 ± 1.05 cm (0.9–6.8 cm)
Specimen weight (g) 30.1 ± 27.5 g (7–133 g)
Number of mass per breast 1.04 ± 0.22 (range 1–3)
0 (microcalcification) 14
1 180





From August 2010 to December 2015, a total of 323
EABS procedures were performed in 286 patients; the
vast majority of whom had unilateral disease (n = 249,
90.5%). The mean age of the patients was 36 ± 13 years
(range, 13–69 years), and the mean tumor size was 2.2 ±
1.1 cm (range, 0.9 to 6.8 cm). Most of the tumors
(93.8%, 303/323) were excised through a transareolar
wound, 2.4% (8/323) through an axillary wound, and
0.3% (1/323) through the infra-mammary fold. The
mean distance from the nipple to the tumor was 5.2 cm
(2–9 cm) (Fig. 1a). The average number of tumors ex-
cised was 1.0 ± 0.2 (range 1–3) per breast. The clinicalmanifestations of patients with benign breast tumors
who received EABS are summarized in Table 1.
The mean operating time was 81.4 ± 30.0 min, the mean
blood loss was 12.0 ± 9.1 ml, and the mean hospital stay
was 2.2 ± 0.4 days (Table 2). Most patients had a smooth
postoperative recovery, and there were no major peri-
operative complications. Overall, the rate of complications
associated with EABS was 6.5% (21/323), and all were
minor and wound-related. Two (0.6%) procedures
resulted in wound infection, which resolved after anti-
biotic therapy, four (1.2%) procedures resulted in
hematoma, and four (1.2%) procedures resulted in poor
wound healing during outpatient follow-up (Table 2).
Of the 323 EABS procedures performed, 163 (50%)
were performed in patients who received biopsy before
the operation. Of those procedures, 144 (44.5%) were
performed in patients who received core needle biopsy
(CNB), 18 (5.5%) were performed in patients who re-
ceived fine needle aspiration cytology (FNAC), and one
was performed in a patient who received both CNB and




Infra-mammary fold 1 (0.3%)
Operation time
Mean operation time (min) 81.4 ± 30.0 min
Single 90 ± 20.6 min (35–150 min)
Bilateral 121.8 ± 44.53 min (70–340 min)
Blood loss evaluation
Blood loss (ml) 12.0 ± 9.1 ml
Single 10.57 ± 3.12 ml (3–30 ml)
Bilateral 21.05 ± 21.37 ml (5–140 ml)
Complication 21 (6.5%)
Hematoma 4 (1.2%)
Wound infection 2 (0.6%)
Seroma 11 (3.4%)
Poor wound healing 4 (1.2%)




Cellular fibroadenoma 4 (1.2%)
Complex fibroadenoma 3 (0.9%)
Juvenile fibroadenoma 6 (1.8%)
Fibroadenoma + fibrocystic change 46 (16.6%)
Fibrocystic change 55 (17%)
Fibrocystic change + adenosis 7 (2.2%)
Phyllodes tumor 10 (3.1%)





DCIS in a fibroadenoma 1 (0.3%)
IDC 1 (0.3%)
LCIS 2 (0.6%)
LCIS + DCIS 1 (0.3%)
Positive margin of malignancy 0/5 (0%)
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vealed 156 (49%) fibroadenomas, 46 (16.6%) fibroadenoma
specimens with fibrocystic change, 55 (17%) specimens
with fibrocystic change, and five (2%) malignant specimens.
Of the 5 patients with malignant disease, CNB showed evi-
dence of benign breast lesion in 2 patients, and microcalci-
fication was detected in 3 patients before the operation. All
5 patients showed negative margins after the initial EABS
procedure, and 1 patient had a margin distance <1 mm.
The 4 patients with margins >1 mm did not receive further
re-excision, and the patient with a margin <1 mm received
further wide excision. The pathology report showed no re-
sidual breast cancer. The pathology reports associated with
the 323 EABS procedures are summarized in Table 3.
To evaluate the learning curve associated with EABS
and survey whether the operating time would decrease
with experience, we compared the operating time with
the number of procedures performed. We observed a
trend in decreasing operating time with experience
(Fig. 3). There was also a trend in decreasing operating
time when we grouped the operations into five groups
according to the sequence in which they were performed
(p < 0.04, Fig. 3b). There was a significant difference in
operating time between the first 50 procedures (the ini-
tial learning phase, mean operating time 89.6 ± 24.5 min)
and the last 50 procedures (the mature phase, mean
operating time 59.9 ± 12.3 min, p < 0.001, Fig. 3c).
A total of 110 (38.5%) patients completed the postop-
erative cosmetic outcome questionnaire. A “very good”
cosmetic outcome was reported by 20 (18.4%) patients, a
“good” outcome was reported by 74 (67.2%) patients, a
“fair” outcome was reported by 14 (12.7%) patients, and apoor outcome was reported by 2 (1.8%) patients (Fig. 4 a).
Of the 110 patients, 86 (78.1%) reported that the surgery
resulted in a symmetrical breast, and 24 (21.8%) reported
that their breast was mildly asymmetric after the surgery
(Fig. 4b). Among the 24 patients who reported mild asym-
metry, 9 (37.5%) reported dimpling of the breast contour,
7 (29.1%) complained that breast size became smaller after
the operation, and 1 (4.1%) patient felt that the contralat-
eral breast (healthy breast) was mildly ptotic compared
with the operated breast. In regard to the willingness to
perform the same procedure if they had to undergo a
second operation, the majority (n = 102, 92.7%) reported
that they would choose the same procedure, 6 (5.5%)
patients were not sure, and 2 (1.8%) patients reported that
they would not want to receive the EABS procedure either
because of wound pain or because it resulted in fair
cosmetic outcome (Fig. 4c).
Discussion
In this study, we reported our preliminary experience
with performing endoscopy-assisted breast surgery for
managing of benign breast tumors. In our analysis of
the 323 EABS procedures performed in 286 patients
with benign breast lesions, we found that most of the
patients were young (mean age 36 years, 63.8%
<40 years) and had moderate to large tumors (mean
2.2 cm) located far away from the areolar complex
(mean 5.2 cm, Fig. 1a).
Fig. 3 Operation learning curve. a Unilateral vs. bilateral OP learning curve. b Unilateral OP time: divided into five groups (43–50 procedures in
each group). Comparison of the average OP time and standard deviation in each group (p < 0.04). c First 50 procedures vs. last 50 procedures in
the OP learning curve
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Fig. 4 Postoperative cosmetic outcome evaluation
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of benign breast tumors. In our patients, 63.5% (202/318)
of the lesions were fibroadenomas. Newer techniques have
been proposed for smaller fibroadenomas, such as percu-
taneous excision [6, 23] or in situ cryoablation [4, 24],
which are less invasive than conventional excision. Percu-
taneous excision performed with the Mammotome or
Encor system has been shown to be appropriate for excis-
ing small or non-palpable masses [6, 23]. Cryoablation,
which achieves complete ablation of the breast mass bythe “freeze-thaw-freeze” technique without the need for
subsequent resection, has been approved by the FDA for
the treatment of fibroadenoma [4, 24]. However, surgical
excision remains the standard treatment for large fibro-
adenomas [5, 7], giant fibroadenomas [25, 26], juvenile
fibroadenomas [27], phyllodes tumors [28], and multiple
fibroadenomas [29, 30].
A circumareolar incision, which leaves the least visible
scar, is a common approach for the management of benign
breast lesions [1, 29, 31, 32]. The cosmetic result is favorable,
and the tumor can usually be adequately resected. Even
giant fibroadenomas have been shown to be successfully re-
moved through a circumareolar incision using the “Swiss-
Roll” operation [31, 32]. However, not all fibroadenomas,
such as those located far away from the areolar complex,
can be managed through a simple circumareolar incision.
An incision above the lesion can result in suboptimal es-
thetic outcomes and is one of the important reasons why
patients are often reluctant to receive surgical excision for
breast tumors even when the disease is symptomatic.
EABS for breast tumors was first used in 1998, when
Kitamura et al. [33] first reported the use of endoscopic
surgery with three small incisions in the mid-axillary line
for removal of benign breast tumors. A modified retro-
mammary space approach was proposed by Osanai et al.
[12, 34] in 2001 and was modified by Liu et al. [14] in
2009 with two or three small incisions located in the
axilla and/or areolar complex. In the current study, a
video-assisted transareolar approach was used to excise
most (97%) of the benign breast tumors. This technique
was initially proposed by Tamaki et al. [15] in 2001 as a
minimally invasive surgical technique that involves per-
forming the surgery through a single periareolar incision.
This technique was refined by Cheng et al. [35] to excise
giant juvenile fibroadenomas (5–10 cm in size) with sub-
sequent retrieval of the specimen with an endoscopic
plastic bag through the periareolar incision.
Transareolar video-assisted breast surgery (as illustrated
in Fig. 2) can be used to excise moderate to large breast
tumors (>2 cm) that are located far from the areolar com-
plex (>4 cm). One of the benefits of the procedure is that
it only leaves a small inconspicuous scar over the areola
and better cosmetic outcome for patient with multiple
tumors. In this study, 85.4% (94/110) of patients reported
being satisfied with the cosmetic result, and all patients
reported that they were satisfied with breast symmetry
after the procedure (Fig. 4). A very high (92.7%) propor-
tion of patients reported that they would choose the same
procedure if they needed surgery in the future.
The main limitation of performing endoscopy-assisted
breast surgery is the need for general anesthesia and
hospitalization. In our study, the mean hospital stay was
2.2 ± 0.4 days as patients chose to be discharged the day
after operation because of insurance concerns (Table 2).
Lai et al. World Journal of Surgical Oncology  (2017) 15:19 Page 8 of 9In fact, some patients were discharged the same day
after recovery from anesthesia. The relatively long oper-
ating time (mean 81.4 ± 30 min) is another limitation for
the widespread use of this surgical technique for benign
breast tumors. As we showed in the learning curve study
(Fig. 3), the operating time decreased significantly from
89.6 ± 24.5 min in August 2010 when we first started to
perform the procedure to 59.9 ± 12.3 min in December
2015 (p < 0.001). Among the 323 EABS procedures per-
formed, 5 (2%) were performed in patient who found to
have malignancy in the final pathologic report (Table 3).
All of the specimens had negative margins, and only one
patient, who had peripheral margin <1 mm, received fur-
ther re-excision, and no residual breast cancer was found.
This indicates that EABS is an effective and oncologically
safe procedure for the management of breast tumors.
Currently, there is no standard for the management of
benign breast tumors [36]. Video-assisted surgery via a
circumareolar incision is a useful technique for peripher-
ally located tumors. It not only allows for excision of the
lesions but also results in an inconspicuous postoperative
scar and hence better cosmetic outcome.
Conclusions
Our preliminary results show that transareolar video-
assisted breast surgery is a safe and effective procedure
with good cosmetic outcome, especially for patients with
moderate to large peripherally located breast tumors.
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